Discover how evolving treatment options are transforming care for patients with HCM, from traditional symptom management to disease-specific therapies. Build practical skills to assess treatment response, monitor patients receiving advanced therapies, and deliver effective patient education that supports safe treatment and improved clinical outcomes.
Learning Objectives
- Explain the pathophysiology and prevalence of HCM including differentiation between obstructive and non-obstructive HCM.
- Differentiate traditional pharmacologic and interventional HCM treatments from emerging disease-specific therapies, including mechanism of action, clinical effects, and role in symptom management.
- Apply evidence-based nursing assessment, monitoring, and patient education strategies for individuals with HCM receiving advanced pharmacologic therapies, including cardiac myosin
CE certificate available upon successful completion of the post-test and program evaluation.
MSN, RN, FNP-C
Accreditation:
PCNA is accredited by the American Association of Nurse Practitioners® as an approved provider of nurse practitioner continuing education. Provider number: 030602. This activity is approved for 0.75 contact hour(s) (which includes 0.0 hour(s) of pharmacology).
